ヘルスケアにおける人間拡張　2023-2028年

出版：Mind Commerce（マインドコマース）　出版年月：2023年6月

Human Augmentation in Healthcare: Bionics, Organ and Body Part Replacement, Exoskeletons, and Robotics 2023 – 2028
ヘルスケアにおける人間拡張：生体工学、臓器・身体部位移植、外骨格、ロボティクス　2023-2028年

レポート目次　　お問合せ・ご注文　　価格・納期について

Mind Commerce（マインドコマース）「ヘルスケアにおける人間拡張：生体工学、臓器・身体部位移植、外骨格、ロボティクス　2023-2028年 – Human Augmentation in Healthcare: Bionics, Organ and Body Part Replacement, Exoskeletons, and Robotics 2023 – 2028」は医療分野における生体工学、臓器移植、外骨格、ロボティクスの市場を調査し、テクノロジーアセスメント、製品およびサービスの総括、応用評価、産業インパクトアセスメント、競合分析などを提供します。また当レポートでは2023年から2028年までの医療向け人間拡張に関する多角的な予測も行っています。

主な掲載内容

1. イントロダクション
2. 生体工学と市場開発
   1. 医療向け生体工学製品
   2. 義肢装具
   3. 人工臓器
   4. 外骨格型パワードスーツ
      1. 医用
      2. 軍用
      3. アシスト用
   5. ヒト向け生体工学
   6. 機械と電子生体工学比較
   7. 人工移植とウェアラブル生体工学比較
   8. 3D印刷と生体工学
   9. 生体工学と人工知能
   10. ナノテクノロジーと生体工学
   11. 生体模倣ビジネス
   12. サイボーグ
   13. 生体工学の業界環境
3. ユースケースと例
4. 人間拡張市場分析と収益予測
5. 企業と分析
6. まとめおよび市場展望

Overview

Human Augmentation represents mechanical and electronic additions to the human body to improve various body functions. In the healthcare sector, augmentation may include bionics, organ replacement, exoskeletons, and robotics to provide assistance to those that have physical impairments. The goals of augmentation are many and varied such as rehabilitation, elder care, work and lifestyle enablement.

In many cases, the goal is to replicate biological methods and systems found in nature via electrically or mechanically powered artificial devices. Examples range from artificial organ or body part replacement to exoskeleton suit or robotics. In the case of collaborative robots (Co-Bots), robotics is used in collaboration with a human being to enable functions that would otherwise be prohibitive due to physical limitations.

Bionics represents the application of biological methods and systems found in nature, leverage to support the healthcare industry via electrically and/or mechanically powered artificial devices. Devices include artificial organs, body parts, and exoskeleton, which either replaces damaged or weakened body parts. These devices act as the original functions very closely. The exoskeleton suit has also been used in other purposes like rehabilitation and elder care.

This human augmentation report addresses the market for bionics, organ replacement, exoskeletons, and robotics in the healthcare sector including technology assessment, product and service review, application evaluation, industry impact assessment, and competitive analysis. The report includes detailed forecasts covering many aspects of human augmentation in healthcare for 2023 through 2028.

Companies in Report:

1. Abbott Laboratories
2. AbbVie Inc.
3. Abiomed
4. Asahi Kasei Kuraray Medical Co. Ltd.
5. Baxter International
6. Bionic Power
7. Boston Scientific Corporation
8. Cochlear Ltd.
9. Edwards Lifesciences Corporation
10. Ekso Bionics Holdings Inc.
11. ExoAtlet
12. LivaNova PLC
13. Lockheed Martin Corporation
14. Medtronic plc
15. Orthofix Holdings Inc.
16. Ossur Corporate
17. Otto Bock HealthCare GmBH
18. RB3D
19. Sarcos Corporation
20. Sonova Holding AG
21. Spring Active
22. SRI International
23. SynCardia Systems LLC
24. Zimmer Biomet Holdings

目次

Table of Contents

Executive Summary

1.0 Introduction

1.1 Bionics Overview
1.2 Bionics Products and Application Industry
1.3 Bionics Growth Drivers
1.3.1 Healthcare Technology Advancement
1.3.2 Aging Population to Increase Organ Failure
1.3.3 Accident to Amputations
1.3.4 Exoskeleton Application
1.3.5 Substitute of Robotics
1.3.6 Government R&D Initiative
1.3.7 Increase of Income Especially in Emerging Economies
1.4 Bionics Market Limitations
1.4.1 High Cost of Device and Treatment
1.4.2 Government Regulations and Strict Approval process
1.4.3 Lack of Surgical Expertise
1.5 Bionics Impact on Society
1.5.1 Positive Impact
1.5.2 Negative Impact

2 Bionics Technology and Market Development

2.1 Medical Bionics Products
2.2 Orthotics and Prosthetics
2.3 Artificial Organ
2.4 Powered Exoskeleton
2.4.1 Medical Exoskeleton
2.4.2 Military Exoskeleton
2.4.3 Assistive Exoskeleton
2.5 Human Bionics
2.6 Mechanical vs. Electronics Bionics
2.7 Artificial Implants vs. Wearable Bionics
2.8 3D Printing and Bionics
2.9 Bionics and Artificial Intelligence
2.10 Nanotechnology and Bionics
2.11 Business Biomimetic
2.12 Cybernetic Organism
2.13 Bionics Industry Landscape

3 Use Cases and Examples

3.1 HELLEN – The Exoskeleton
3.2 Tracking and Predicting Epilepsy Seizures
3.3 Designing an Exoskeleton for Fitness
3.4 Robotic Exoskeleton Case Study
3.5 ReWalk Exoskeleton
3.6 Magnetic Encoders Allows the Building of ‘Life-Changing’ Exoskeletons
3.7 Indego Exoskeleton

4 Human Augmentation Market Analysis and Revenue Forecasts

4.1 Combined Bionics Revenue 2023 – 2028
4.2 Bionics Revenue by Industry Vertical 2023 – 2028
4.3 Medical Bionics Revenue 2023 – 2028
4.3.1 Medical Bionics Revenue by Product Category
4.3.2 Medical Bionics Revenue by Application Type
4.3.3 Implantable Medical Bionics Revenue by Product Type
4.3.4 Medical Bionics Revenue by Technology Type
4.3.5 Medical Mechanical Bionics Revenue by Product Type
4.3.6 Medical Bionics Revenue by End User Type
4.3.7 Medical Bionics Revenue by Region
4.3.8 North America Medical Bionics Revenue by Country
4.3.9 Europe Medical Bionics Revenue by Country
4.3.10 APAC Medical Bionics Revenue by Country
4.3.11 LAMEA Medical Bionics Revenue by Country
4.4 Defense Exoskeleton Bionics Revenue 2023 – 2028
4.4.1 Defense Exoskeleton Bionics Revenue by Product Category
4.4.2 Defense Exoskeleton Bionics Revenue by Technology Type
4.4.3 Defense Exoskeleton Bionics Revenue by Region
4.4.4 North America Defense Exoskeleton Bionics Revenue by Country
4.4.5 APAC Defense Exoskeleton Bionics Revenue by Country
4.4.6 Europe Defense Exoskeleton Bionics Revenue by Country
4.4.7 ROW Defense Exoskeleton Bionics Revenue by Country

5 Company and Analysis

5.1 Strategic Initiatives
5.2 Abbott Laboratories
5.3 AbbVie Inc.
5.4 Abiomed
5.5 Asahi Kasei Kuraray Medical Co. Ltd.
5.6 Baxter International
5.7 Zimmer Biomet Holdings
5.8 Boston Scientific Corporation
5.9 Cochlear Ltd.
5.10 Edwards Lifesciences Corporation
5.11 Ekso Bionics Holdings Inc.
5.12 LivaNova PLC
5.13 Medtronic plc
5.14 Orthofix Holdings Inc.
5.15 Otto Bock HealthCare GmBH
5.16 Sonova Holding AG
5.17 Ossur Corporate
5.18 SynCardia Systems LLC
5.19 Bionic Power
5.20 ExoAtlet
5.21 Lockheed Martin Corporation
5.22 RB3D
5.23 Sarcos Corporation
5.24 Spring Active
5.25 SRI International

6 Conclusions and Market Outlook

Figures

Figure 1: Bionics Product and Application Ecosystem
Figure 2: Bionics Industry Landscape
Figure 3: Global Bionics Market Revenue 2023 – 2028

Tables

Table 1: Global Bionics Revenue by Industry Vertical 2023 – 2028
Table 2: Global Medical Bionics Revenue by Product Category 2023 – 2028
Table 3: Global Orthopaedic Bionics Revenue by Product Type 2023 – 2028
Table 4: Global Bionics Limbs Revenue by Product Type 2023 – 2028
Table 5: Global Bionics Lower Limbs Revenue by Product Type 2023 – 2028
Table 6: Global Electrical Bone Growth Stimulators Revenue by Product Type 2023 – 2028
Table 7: Global Cardiac Bionics Revenue by Product Type 2023 – 2028
Table 8: Global Artificial Organs Revenue by Product Type 2023 – 2028
Table 9: Global Artificial Heart Valves Revenue by Product Type 2023 – 2028
Table 10: Global Bionics Pacemaker Revenue by Product Type 2023 – 2028
Table 11: Global Bionics Ventricular Assist Device (VADs) Revenue by Product Type 2023 – 2028
Table 12: Global Neural/Brain Bionics Revenue by Product Type 2023 – 2028
Table 13: Global Bionics Internal Neurostimulators Revenue by Product Type 2023 – 2028
Table 14: Global Bionics Ear Revenue by Product Type 2023 – 2028
Table 15: Global Medical Bionics Revenue by Application Type 2023 – 2028
Table 16: Global Implantable Medical Bionics Revenue by Product Type 2023 – 2028
Table 17: Global Externally Worn Medical Bionics Revenue by Product Type 2023 – 2028
Table 18: Global Medical Bionics Revenue by Technology Type 2023 – 2028
Table 19: Global Medical Mechanical Bionics Revenue by Product Type 2023 – 2028
Table 20: Global Medical Electronic Bionics Revenue by Product Type 2023 – 2028
Table 21: Global Medical Bionics Revenue by End User Type 2023 – 2028
Table 22: Medical Bionics Revenue by Region 2023 – 2028
Table 23: North America Medical Bionics Revenue by Country 2023 – 2028
Table 24: Europe Medical Bionics Revenue by Country 2023 – 2028
Table 25: APAC Medical Bionics Revenue by Country 2023 – 2028
Table 26: SEA Medical Bionics Revenue by Country 2023 – 2028
Table 27: LAMEA Medical Bionics Revenue by Country 2023 – 2028
Table 28: Global Defense Exoskeleton Bionics Revenue by Product Category 2023 – 2028
Table 29: Global Defense Exoskeleton Revenue by Technology Type 2023 – 2028
Table 30: Defense Exoskeleton Bionics Revenue by Region 2023 – 2028
Table 31: North America Defense Exoskeleton Bionics Revenue by Country 2023 – 2028
Table 32: APAC Defense Exoskeleton Bionics Revenue by Country 2023 – 2028
Table 33: Europe Defense Exoskeleton Bionics Revenue by Country 2023 – 2028
Table 34: ROW Defense Exoskeleton Bionics Revenue by Country 2023 – 2028